The price of TC BioPharm (Holdings) plc ADR (NASDAQ: TCBP) closed at $1.31 in the last session, down -8.39% from day before closing price of $1.43. In other words, the price has decreased by -$0.1200 from its previous closing price. On the day, 392347 shares were traded.
Ratios:
We take a closer look at TCBP’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 1.09 and its Current Ratio is at 1.09. In the meantime, Its Debt-to-Equity ratio is 1.16 whereas as Long-Term Debt/Eq ratio is at 0.83.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TCBP now has a Market Capitalization of 3.47M and an Enterprise Value of 3.99M. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.27 while its Price-to-Book (P/B) ratio in mrq is 102.18. Its current Enterprise Value per Revenue stands at 1.40 whereas that against EBITDA is -3.34.
Stock Price History:
Over the past 52 weeks, TCBP has reached a high of $44.00, while it has fallen to a 52-week low of $0.85. The 50-Day Moving Average of the stock is 1.4040, while the 200-Day Moving Average is calculated to be 54.3968.
Shares Statistics:
According to the various share statistics, TCBP traded on average about 3.30M shares per day over the past 3-months and 630.22k shares per day over the past 10 days. Shares short for TCBP as of Mar 15, 2024 were 638.72k with a Short Ratio of 0.19, compared to 207.53k on Feb 15, 2024. Therefore, it implies a Short% of Shares Outstanding of 26.32% and a Short% of Float of 26.32%.
Earnings Estimates
The company has 0 analysts who recommend its stock at the moment. The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.
Analysts are recommending an EPS of between $0 and $0 for the fiscal current year, implying an average EPS of $0. EPS for the following year is $0, with 0 analysts recommending between $0 and $0.
